SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

Sleep

Is Trazodone a Good Sleep Aid?

Trazodone is one of the most frequently prescribed off-label sleep aids, and many people find it helpful. It is non-habit-forming and inexpensive, but it is not FDA-approved for insomnia, and its evidence base is more limited than behavioral treatment (CBT-I). A clinician can judge whether it fits your situation.

Talk to a clinician

Amelia Reyes, LCSW — Behavioral Health Clinician

anxiety, depression & burnout. Gale can match you with a licensed clinician for a visit.

Find care →

What is trazodone, and why is it used for sleep?

Trazodone is classified as a serotonin antagonist and reuptake inhibitor (SARI). Its FDA-approved use is major depressive disorder, but at the lower doses typically used for sleep (25–100 mg), its sedating properties dominate 1. At these doses, the drug's primary mechanism involves blocking serotonin 5-HT2A receptors, histamine H1 receptors, and alpha-1-adrenergic receptors — all of which normally promote wakefulness 1.

The antidepressant effect of trazodone requires much higher doses (150–600 mg), which activate serotonin reuptake inhibition. At insomnia doses, that mechanism is largely absent, which is why trazodone is sometimes described as a different drug at different doses 1.

Off-label use for insomnia has become so common that trazodone is now prescribed for sleep more often than for depression in the United States 2. It is not FDA-approved for sleep disorders, and the American Academy of Sleep Medicine's 2017 pharmacologic guideline issued a weak recommendation against its use for sleep onset or maintenance insomnia, citing limited evidence 3. This is not the same as saying trazodone is ineffective — the recommendation reflects the evidence quality available, not a clinical consensus that it never helps.

What does the research actually show?

A 2017 systematic review examining 45 studies from 1983 to 2016 found that trazodone reduces sleep latency (time to fall asleep) and increases total sleep duration across a range of populations, including people with primary insomnia and those with comorbid depression 2. A 2022 systematic review and meta-analysis using polysomnographic data found that trazodone significantly increased total sleep time (roughly 40 minutes) and reduced time to fall asleep (roughly 19 minutes) compared to placebo, while also meaningfully increasing time spent in deep sleep (N3) without significantly changing REM sleep 4.

Those are real effects. But the evidence base is thinner than for established hypnotics, and head-to-head comparisons with zolpidem (Ambien) suggest zolpidem may have a modest advantage for sleep latency at equivalent study doses, though zolpidem carries its own risks 2.

The honest picture: trazodone works for many people, the effect is reasonably well-documented, but the data are less extensive and less consistent than the scale of its prescribing might imply.

Why do clinicians choose it over alternatives?

Trazodone offers a practical clinical profile that explains its widespread use:

  • Not a controlled substance. Benzodiazepines (temazepam, triazolam) and Z-drugs (zolpidem, eszopiclone) are Schedule IV controlled substances carrying dependence risk, stricter prescribing limits, and federal scheduling requirements. Trazodone has none of these concerns.
  • Inexpensive as a generic. The cost barrier is low.
  • No significant REM suppression at insomnia doses. Many sedating medications suppress REM sleep, which affects dream consolidation and cognitive recovery. The 2022 meta-analysis found trazodone did not meaningfully alter REM 4.
  • Dual-purpose when mood symptoms are present. For people who have both insomnia and depression or anxiety — a very common pairing — the option to address both with a single medication has practical appeal.

These are real advantages. The choice is not simply that trazodone is safer — it is that the risk profile is different, and for some patients, that profile fits better.

What are the real trade-offs and side effects?

No sleep medication is side-effect-free. The most common adverse effects with trazodone are daytime drowsiness, dizziness, dry mouth, headache, and occasionally nausea 12. Dose timing matters: taking trazodone too early in the evening can produce morning grogginess; adjusting the timing often helps.

Orthostatic hypotension. Trazodone lowers blood pressure, and standing up quickly after taking it can cause lightheadedness or dizziness. This effect is more pronounced in older adults and in people with existing low blood pressure or hypertension. A 2025 study of geriatric outpatients with hypertension found that trazodone users had a significantly higher incidence of syncope and falls compared with non-users (58.3% vs. 21.2%) 5. This is a clinically meaningful risk in that population.

Priapism. Trazodone is the most commonly implicated medication in drug-induced priapism — a prolonged, painful erection unrelated to arousal. The estimated incidence is roughly 1 in 1,000 to 1 in 10,000 patients 21. While rare, it is a urological emergency: untreated priapism can cause permanent erectile dysfunction. Any person assigned male at birth who experiences a prolonged painful erection after taking trazodone should seek emergency care immediately.

Drug interactions. Because trazodone has serotonergic activity, combining it with other serotonergic medications (SSRIs, SNRIs, MAOIs, certain migraine drugs) raises the risk of serotonin syndrome 1. A thorough medication review is essential before starting.

Boxed warning. Like all antidepressant-class medications, trazodone carries an FDA boxed warning about increased risk of suicidal thoughts in children, adolescents, and young adults, particularly when starting treatment or changing doses. Clinicians monitor for mood changes in this context.

How does trazodone compare to CBT-I, the behavioral treatment for insomnia?

The treatment with the most robust and durable evidence for chronic insomnia is Cognitive Behavioral Therapy for Insomnia (CBT-I) — a structured program that addresses the thoughts and behaviors driving poor sleep, without medication. The American Academy of Sleep Medicine designates CBT-I as the preferred first-line treatment for chronic insomnia disorder in adults 6. A 2015 meta-analysis found CBT-I produced significant, lasting improvements in sleep outcomes — and evidence suggests these gains persist longer than those from medication alone 7.

Medication, including trazodone, tends to work while you take it. CBT-I teaches the nervous system to sleep differently. They are not mutually exclusive — some people use both — but the honest framing is that medication alone does not change the underlying patterns driving chronic insomnia.

Access to CBT-I remains a real barrier. Therapists trained in it are not universally available, and cost or wait times can be prohibitive. Digital CBT-I programs (apps and telehealth platforms) have expanded access, and some insurers now cover them. A clinician can help identify what is realistically available to you.

Who should be particularly cautious with trazodone?

Certain groups warrant extra attention when considering trazodone:

  • Adults over 65. The fall and orthostatic hypotension risk is higher in this group 5. Some clinical guidelines and the American Geriatrics Society flag trazodone for cautious use in older adults.
  • People on other serotonergic medications. SSRIs, SNRIs, MAOIs, and some migraine medications interact. A medication review is required before starting 1.
  • People with cardiac arrhythmia or QT prolongation history. Trazodone can affect cardiac conduction, particularly at higher doses.
  • People who are pregnant or breastfeeding. The risk-benefit balance requires evaluation with an obstetrician and prescribing clinician.
  • People assigned male at birth. The priapism risk, while rare, is real and requires awareness before starting.

What to bring to a conversation with a clinician

A clinician evaluating whether trazodone makes sense for you will want to understand:

  • How long the sleep problem has been present, and whether it is difficulty falling asleep, staying asleep, or both
  • Whether you have tried behavioral approaches, including CBT-I
  • Whether depression, anxiety, or another mood or psychiatric condition is part of the picture — because that changes the treatment calculation
  • A complete list of all current medications, supplements, and substances (including alcohol and recreational drugs)
  • Any history of low blood pressure, cardiac arrhythmia, fall risk, or past reactions to sleep medications

Screening tools like the PHQ-9 for depression 8 and GAD-7 for anxiety 9 are often used in this context. If obstructive sleep apnea (OSA) is suspected — particularly if there is snoring, witnessed breathing pauses, or daytime sleepiness — a sleep study may be appropriate before or alongside any pharmacological treatment, since OSA can persist despite medication 10.

The Insomnia Severity Index (ISI) is a validated tool clinicians sometimes use to characterize and track insomnia 11.

Common questions

Is trazodone FDA-approved for sleep?

No. Trazodone is FDA-approved only for major depressive disorder. Its use for insomnia is off-label — meaning clinicians prescribe it for a purpose outside the approved label, which is legal and common, but means the approval process did not specifically evaluate it for that use. The American Academy of Sleep Medicine's pharmacologic guideline issued a weak recommendation against its use for insomnia, reflecting limited rather than clearly negative evidence.

Can trazodone be taken long-term for sleep?

Some people take it for extended periods, and it does not carry the physical dependence risks of benzodiazepines or Z-drugs. That said, long-term data are limited, and most clinicians prefer pairing it with a plan — whether a trial of CBT-I, a taper schedule, or regular reassessment. Whether long-term use makes sense depends on your situation and is a conversation to have with your prescribing clinician.

What dose of trazodone is typically used for sleep?

Insomnia doses are much lower than antidepressant doses — typically 25 to 100 mg taken before bed. Most of the evidence supporting sleep use comes from studies in this range. Decisions about the right starting dose and any adjustments are for your clinician to make based on your health history and other medications.

How does trazodone compare to Ambien (zolpidem)?

Both are used for insomnia. Zolpidem is FDA-approved for sleep and may have a modest edge for sleep latency in direct comparisons. Trazodone is not FDA-approved for sleep but avoids the controlled-substance concerns of zolpidem — no dependence scheduling, no federal prescribing limits. Neither is a substitute for addressing the root drivers of insomnia. The choice between them depends on individual factors including other medications, health history, and goals.

Is trazodone safe for older adults?

Trazodone requires extra caution in older adults. The risk of orthostatic hypotension, dizziness, and falls is meaningfully higher in this group, and the American Geriatrics Society includes it among medications to use carefully. If you or a family member is over 65, this is worth discussing explicitly with the prescribing clinician.

Talk to a clinician

Amelia Reyes, LCSW — Behavioral Health Clinician

anxiety, depression & burnout. Gale can match you with a licensed clinician for a visit.

Find care →

When to seek immediate or urgent care

  • —A prolonged, painful erection lasting more than two to four hours after taking trazodone — this is a medical emergency; go to an emergency department immediately
  • —Signs of serotonin syndrome: agitation, rapid heart rate, high temperature, muscle twitching or rigidity, especially if combining trazodone with other serotonergic medications — call 911 or go to an emergency department
  • —Severe dizziness, fainting, or loss of consciousness after starting trazodone
  • —Worsening depression, new or worsening thoughts of self-harm or suicide after starting or changing the dose of any antidepressant-class medication — contact a clinician or call 988 (Suicide and Crisis Lifeline)

If you develop a prolonged painful erection or signs of serotonin syndrome (agitation, rapid heart rate, fever, muscle twitching) after taking trazodone, call 911 or go to the nearest emergency department immediately. For a mental health crisis or thoughts of suicide, call or text 988.

This article is general health information only. It is not a diagnosis, medical advice, or a substitute for evaluation by a licensed clinician. Trazodone is a prescription medication; decisions about starting, adjusting, or stopping it must be made with a prescribing clinician who knows your complete health history and current medications.

References

  1. 1.Shin JJ, Saadabadi A (2024). Trazodone. StatPearls, NCBI Bookshelf. PMID 29262060 ✓Mechanism of action (5-HT2A, H1, alpha-1 blockade at low doses), FDA-approved use, off-label insomnia use at 50-100 mg, side effect profile including orthostatic hypotension and priapism, drug interactions with MAOIs and serotonergic agents
  2. 2.Jaffer KY, Chang T, Vanle B, Dang J, Steiner AJ, Loera N, Abdelmesseh M, Danovitch I, IsHak WW (2017). Trazodone for Insomnia: A Systematic Review. Innovations in Clinical Neuroscience. PMID 29552421 ✓Off-label use prevalence, evidence across 45 studies for sleep latency reduction and duration increase, priapism incidence 1 in 1,000-10,000, comparison with zolpidem, side effect profile
  3. 3.Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017). Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. doi:10.5664/jcsm.6470 ✓AASM weak recommendation against trazodone for sleep onset or maintenance insomnia due to limited evidence
  4. 4.Zheng Y, Lv T, Wu J, Lyu Y (2022). Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis. Scientific Reports. doi:10.1038/s41598-022-18776-7 ✓Trazodone increased total sleep time by approximately 40 minutes, reduced sleep latency by approximately 19 minutes, increased N3 deep sleep, did not significantly alter REM sleep
  5. 5.Rivasi G, Capacci M, Del Re LM, Ambrosino I, Ceolin L, Liccardo A, Bisignano MF, D'Ambrosio G, Ceccarelli G, Matteucci G, Mossello E, Ungar A (2025). Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension. Drugs & Aging. doi:10.1007/s40266-025-01196-3 ✓Trazodone users in geriatric hypertensive population had significantly higher incidence of syncope and falls (58.3% vs 21.2% in non-users); elevated orthostatic blood pressure drop
  6. 6.Edinger JD, Arnedt JT, Bertisch SM, et al. (2021). Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. doi:10.5664/jcsm.8986 ✓AASM strong recommendation for CBT-I as first-line treatment for chronic insomnia disorder in adults
  7. 7.Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D (2015). Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Annals of Internal Medicine. doi:10.7326/M14-2841 ✓CBT-I produces significant and durable improvements in sleep outcomes for chronic insomnia
  8. 8.Kroenke K, Spitzer RL, Williams JBW (2001). The PHQ-9: Validity of a Brief Depression Severity Measure. Journal of General Internal Medicine. doi:10.1046/j.1525-1497.2001.016009606.x ✓PHQ-9 as validated depression screening tool relevant to insomnia evaluation
  9. 9.Spitzer RL, Kroenke K, Williams JBW, Lowe B (2006). A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Archives of Internal Medicine. doi:10.1001/archinte.166.10.1092 ✓GAD-7 as validated anxiety screening tool relevant to insomnia evaluation with mood comorbidity
  10. 10.Kapur VK, Auckley DH, Chowdhuri S, et al. (2017). Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. doi:10.5664/jcsm.6506 ✓OSA as a condition that can coexist with or mimic insomnia; sleep study consideration before or alongside pharmacological treatment
  11. 11.Morin CM, Belleville G, Belanger L, Ivers H (2011). The Insomnia Severity Index: Psychometric Indicators to Detect Insomnia Cases and Evaluate Treatment Response. Sleep. doi:10.1093/sleep/34.5.601 ✓ISI as validated clinical tool for characterizing and tracking insomnia severity

11 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.